Exactly!! This is beyond ridiculous and every single person
Exactly!! This is beyond ridiculous and every single person knows it, only the honest will say so. There was absolutely no reason for Doc to say we could launch after Medicare approval if everything was not ready and waiting. There was no reason to say we'd uplist in Q1 2021 and still not be upliststed in Q3 of 2022. No leader, much less a CEO should be so lost as to th3 process that they miss launch or uplist dates by YEARS. Even recently Doc says positive results in Q2 and Farnworth says before July 1st. So much for the double conformation. That and the lack of honest communication on the direction of the company should infuriate everyone. It appears we are either being mislead and lied to, or now we've got 2 incompetent men running Unvc
I don't know if things we've been promised will ever come to fruition. I'm hoping Doc is just and old man who didn't realize the complexities of what he's trying to do and got way ahead of himself saying "Cigars soon" " get on this train" etc... I hope he has qualified people getting this done but it remains to be seen.
Hope can be a good or bad thing. It can get one through tough times but it can also make one wait for something that has no chance of happening. Remember the quote from the Matrix. "Hope is the quentissential human delusion,, simultaneously the source of your greatest strength and your greatest weakness".
Are we delusional for hoping Doc delivers on his promises?
5
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Stocks Lift as Wall Street Awaits Inflation Data Every trader's favorite game—speculation—returns as major U.S. stock benchmarks kick off Monday with some gusto. The S&P 500, Nasdaq Composite, Dow Jones Industrial Average, and Russell 2000 all saw gains in the early morning session, signaling positive vibes across the board. Numbers don't lie, folks: The S&P climbed...
Continue Reading
Rolling Toward an Autonomous Future Alright, gearheads and tech buffs alike, gather 'round for a ride into the future of road travel. AutoMobility LA, a brainchild of the Los Angeles Auto Show, is revving up to give us a sneak peek into the era where cars don't just roll—they think. "The future's not about who's behind the wheel, but who's crafting the brain of the...
Continue Reading
Hyperscale's Bold Move: Exchange Offer Hits the Market Man, when a company believes its market value is out of whack, you get moves like this. Hyperscale Data, strutting under ticker symbol NYSE:GPUS, is swinging for the fences with an exchange offer, aiming to mop up $50 million worth of its common stock with a sweet deal that’s sure to grab any investor's attention....
Continue Reading
Sizing Up Cloud Software Group’s Recent Maneuver Whoever thought navigating debt was a dull spectacle hasn’t kept up with Cloud Software Group's recent financial theatrics. With a $2 billion cap on the table, their cash tender offer for 9.00% Senior Secured Second Lien Notes due 2029 didn’t just happen; it paraded onto the financial stage and left a noteworthy...
Continue Reading
Chipotle's BOGO Charade: A Tattooed Affair You've got to hand it to Chipotle—they know how to turn heads and wallets with their quirky promotions. The upcoming 'Tatted Like a Chipotle Bag' offer is a prime example of how they ride the cultural zeitgeist as they gear up for another record-breaking day on Friday, November 13. And seriously, with tattoos in play, they're...
Continue Reading
Gearing Up for Space Medicine: Enter Energenesis With the cosmic frontier drawing investor eyes and day-to-day operations inching skyward, here comes Energenesis Biomedical (TWSE: 6657), poking its head into space medicine. This isn’t just another biotech firm looking to throw drugs at terrestrial problems. No, Energenesis shot its shot at TASTI 2026 with its...
Continue Reading
Climbing High: Guizhou's Tourism Summit The 2026 International Conference of Mountain Tourism and Outdoor Sports in Guizhou has kicked off with a heartfelt focus on merging natural allure with modern tourism. This isn't just another gathering; it's a powerhouse of international dialogue harbored right in China's dramatic landscape. Building on Unique Natural Assets...
Continue Reading
Financial Revolution: Bybit Steals the Spotlight Ever been to a tech show where financial bigwigs mingle with code geeks? Well, that's exactly the scene unfolding at the famed Web Summit 2026, with Bybit throwing down the gauntlet as an official partner. The MEO Arena in Lisbon is buzzing more than a stock ticker on a rollercoaster day, as Bybit flaunts its wares to a...
Continue Reading
Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...
Continue Reading
Out in Silicon Valley, where innovation isn’t just a buzzword, the National Society of Autism Professionals (NSAP) is stirring the pot with some serious leadership moves. Just this month, they cobbled together their inaugural board of directors—a gathering of eight experts from every corner of the autism field you can think of. They’re not playing small ball, no...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of Municipality Finance's New Notes Issuance Municipality Finance Plc has announced its latest financing initiative, issuing EUR 25 million in notes under its Medium Term Note (MTN) program. This strategic move aims to provide funding for various projects aimed at enhancing sustainability and improving public infrastructure. Details of the Notes Issued The notes...
Continue Reading
Notable Insider Transaction at Nordson Annette K Clayton, a Board Member at Nordson (NASDAQ:NDSN), has made headlines by disclosing a significant stock purchase recently through a new SEC filing. What Triggered This Purchase? According to the Form 4 filing, Clayton acquired 930 shares of Nordson stock, amounting to an impressive total of approximately $215,713. This move...
Continue Reading
Lantheus Holdings to Shine at the Upcoming Conference Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent name in the radiopharmaceutical sector, recently made waves by announcing that the CEO, Brian Markison, will take the stage at the Morgan Stanley 23rd Annual Global Healthcare Conference. The presentation is scheduled for 7:00 a.m. ET on an upcoming Tuesday, where...
Continue Reading
DeepHealth and CARPL.ai: A Collaboration for AI Innovation DeepHealth, a wholly-owned subsidiary under the umbrella of RadNet, Inc. (NASDAQ: RDNT), is embarking on an exciting collaboration with CARPL.ai, a leader in AI orchestration. This strategic partnership aims to develop a novel AI control system tailored for clinical image interpretation to drive enhanced...
Continue Reading
The stock market is navigating through exciting times, with the S&P 500 recently eclipsing the significant milestone of 5,700 points. This robust performance is fueled by a dynamic shift as investors increasingly look towards emerging sectors, particularly healthcare, which is gaining momentum this earnings season. This year, we've seen an impressive trend, with over 40...
Continue Reading